Cannabis is proving to have solid elements for clinical trials in many sectors where diseases may be getting ahead of the treatments. Thanks to the legalization boom in the US and Canada, more and more companies are placing heavy efforts on studies to discover the possibilities of using cannabis to treat serious ailments, like skin cancer.
According to the American Cancer Society, skin cancer is the most common type accounting for over 5 million cases per year. This category holds many different variations, however, the main three types are basal cell carcinomas, squamous cell carcinomas, and melanomas; the rest are considered rare.
If mistreated, the varying main types of skin cancer can spread all over the body. However, they can also be properly treated if discovered within an early diagnosis. As such, thus lies the question: can cannabis treat skin cancer?
Melanomas develop in specific areas like the neck and face and can be more serious than their counterparts. Basal and squamous cell cancers, on the other hand, are developed based on a person’s sun exposure, they mostly develop in the head and neck.
Skin treatment, either cosmetic or medical has been one of the many sectors revitalized by cannabis research. With the development of oils based on cannabidiol (CBD) or tetrahydrocannabinol (THC).
Can cannabis treat skin cancer? Need for treatment
When it comes down to the actual way these ointments or oils work, Medical Marijuana details CBD oils having potential to combat melanoma “[t]hrough its ability to control cell growth and death.”
Despite a complicated legal situation in the US, Attorney General Jeff Sessions is seeminglt rampant on his stance against cannabis, putting patients at risk of choosing between being “illegally alive or legally dead.”
Medical research from the University of Colorado Anschutz Medical Campus showed that the anti-inflammatory sensibilities of cannabinoids are the main reason why they may be a potent agent in combating some melanomas, the more serious skin cancer type.
A 2015 study provided treatment for mice with melanoma using a THC and CBD mix. The researchers found the treatment killed the melanoma cells.
“The cannabinoids did this by facilitating two natural processes of cell death known as autophagy and apoptosis,” the study allegedly concluded.
Can cannabis treat skin cancer? Early stages of research
When it comes to whether can cannabis treat skin cancer or not, fully realized products or serious research is still in the early stage with public companies. That said, the possibilities are so vast that many companies entering the landscape are either focused on many medical aspects or a very particular type. Skin treatment is still being worked on and assessed as far a viable product goes, but there isn’t yet a specific product accessible to everyone and approved by regulatory agencies.
Cannabis Science (OTCMKTS:CBIS) is a company working medical marijuana research and development. The company has a focus on skin cancers, HIV/Aids, and neurological treatments.
Over a one-year period, Cannabis Science has seen a massive growth in their share price, increasing 285 percent, although it is down 6.38 percent year-to-date.
PharmaCyte Biotech (OTCQB:PMCB) has recently entered the cannabinoids space but they are hoping to develop, thanks to some key acquisitions, therapies on “carefully chosen cannabinoid molecules” treating cancer.
Year-to-date the company’s stock has seen a 53.66 dip, while over a one-year period it has gone up 1.62 percent.
Speculation in the sector can be wide as companies may direct their efforts towards one aspect of the CBD potential, but still be aware of medical purposes. For example, Metatron (OTCPINK:MRNJ) is a new player into the cannabinoid-based products, and while commercially they are looking to launch a coffee specialty blend infused with CBD, they have also taken steps to look at the potential CBD provide against skin cancer.
Is there a company that should be added to the list? Let us know in the comments!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
Source: New feed